Adage Capital Partners
IMVTW

Adage Capital Partners’s Immunovant, Inc. Warrants expiring 12/18/2024 IMVTW Stock Holding History

Adage Capital Partners’s Portfolio IMVTW Stock Details IMVTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,020,000
Closed -$2.45M – 824
2020
Q1 		$2.45M Hold
1,020,000
– – 0.01% 643
2019
Q4 		$2.04M Buy
+1,020,000
New +$2.07M 0.01% 659

Adage Capital Partners's IMVTW Position: Q2 2020 in Review

Adage Capital Partners sold out of Immunovant, Inc. Warrants expiring 12/18/2024 (IMVTW) in Q2 2020, closing a stake of 1,020,000 shares — an estimated $2.45M sold.

Adage Capital Partners first reported a position in IMVTW in Q4 2019 and held it in 2 quarters. The position peaked at $2.45M in Q1 2020. 0 funds tracked by Wall St. Rank hold IMVTW as of Q2 2020.

  • Adage Capital Partners reported no remaining Immunovant, Inc. Warrants expiring 12/18/2024 position as of Q2 2020 after selling out during the quarter.
  • Adage Capital Partners sold 1,020,000 Immunovant, Inc. Warrants expiring 12/18/2024 shares in Q2 2020, an estimated $2.45M.
  • Adage Capital Partners first reported a position in Immunovant, Inc. Warrants expiring 12/18/2024 in Q4 2019 and held it in 2 quarters.
  • Adage Capital Partners's Immunovant, Inc. Warrants expiring 12/18/2024 position peaked at $2.45M in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Immunovant, Inc. Warrants expiring 12/18/2024 as of Q2 2020.

Based on Adage Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.